- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2013
- Public Summary Document (PSD) March 2013 PBAC Meeting - PDF
Eribulin mesilate – March 2013
Eribulin Mesilate, solution for injection, 1mg in 2mL Halaven®
Last updated
8 November 2023